BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1006@pharmaconomics
DTSTAMP:20260707T050804Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:ARMP PDUFA — AP-SA02
DESCRIPTION:The FDA's approval decision on AP-SA02 for complicated bacteremia caused by Staphylococcus aureus is due Mar 27\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/921114/000110465926060299/armp-20260512xex99d1.htm\n\nTrack it: https://www.pharmaconomics.com/e/1006
URL:https://www.pharmaconomics.com/e/1006
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ARMP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR